Yahoo
KOSDAQ - Delayed Quote KRW

NOVAREX Co.,Ltd. (194700.KQ)

8,650.00 +60.00 (+0.70%)
At close: 3:30:30 PM GMT+9
Chart Range Bar
Loading chart for 194700.KQ
  • Previous Close 8,590.00
  • Open 8,520.00
  • Bid 8,650.00 x --
  • Ask 8,710.00 x --
  • Day's Range 8,480.00 - 8,800.00
  • 52 Week Range 8,410.00 - 18,450.00
  • Volume 76,413
  • Avg. Volume 103,212
  • Market Cap (intraday) 153.579B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield 400.00 (4.66%)
  • Ex-Dividend Date Dec 29, 2025
  • 1y Target Est --

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Korea.

www.novarex.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

194700.KQ
38.21%
KOSPI Composite Index (^KS11)
19.09%

1-Year Return

194700.KQ
47.99%
KOSPI Composite Index (^KS11)
26.94%

3-Year Return

194700.KQ
22.66%
KOSPI Composite Index (^KS11)
106.79%

5-Year Return

194700.KQ
47.01%
KOSPI Composite Index (^KS11)
69.41%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY24
Revenue 82.15B
Earnings --
Profit Margin 0.00%

Q1

FY24

Q2

FY24

Q3

FY24

Q4

FY24

0
20B
40B
60B
80B
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.76%

  • Return on Assets (ttm)

    8.29%

  • Return on Equity (ttm)

    15.15%

  • Revenue (ttm)

    404.26B

  • Net Income Avi to Common (ttm)

    35.42B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.68B

  • Total Debt/Equity (mrq)

    14.10%

  • Levered Free Cash Flow (ttm)

    -4.1B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: